The Clinical and Pathological Characteristics of Malignant Struma Ovarii: An Analysis of 144 Published Patients
2021 · Frontiers in Oncology · 58 citations
https://doi.org/10.3389/fonc.2021.645156
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
150
Papers
1.8K
Citations
22
h-index
54
i10-index
Lin Liao is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Thyroid Cancer Diagnosis and Treatment & Diabetes Treatment and Management & Metabolism, Diabetes, and Cancer. The author has an h-index of 22, co-authored 128 publications.
ORCID: 0000-0002-0278-4879Papers by this author
worksMacular hole surgery recovery with and without face-down posturing: a meta-analysis of randomized controlled trials
2019 · BMC Ophthalmology · 40 citations
https://doi.org/10.1186/s12886-019-1272-1
Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
2020 · BMC Cancer · 21 citations
https://doi.org/10.1186/s12885-020-07299-x
Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing KATP channel
2018 · Molecular Medicine · 12 citations
https://doi.org/10.1186/s10020-018-0042-5
Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
2024 · Renal Failure · 8 citations
https://doi.org/10.1080/0886022x.2024.2354444
Thyroid dysfunction induced by anti-PD-1 therapy is associated with a better progression-free survival in patients with advanced carcinoma
2023 · Journal of Cancer Research and Clinical Oncology · 5 citations
https://doi.org/10.1007/s00432-023-05364-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat